Viewing Study NCT00003358


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2026-02-23 @ 3:01 PM
Study NCT ID: NCT00003358
Status: COMPLETED
Last Update Posted: 2013-01-16
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module